A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy

Trial Profile

A Multi-center Study to Evaluate the Pharmacokinetics of 21-Desacetyldeflazacort and the Safety of Deflazacort After Oral Administration of Deflazacort Tablets to Children and Adolescent Subjects With Duchenne Muscular Dystrophy

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Deflazacort (Primary)
  • Indications Duchenne muscular dystrophy
  • Focus Pharmacokinetics
  • Sponsors Marathon Pharmaceuticals
  • Most Recent Events

    • 20 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 22 Sep 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
    • 10 Mar 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top